Effect of Analgesic Opioid Drugs on Opioid Receptor Genes Expression in HL-1 Mouse Cardiac Myocytes
DOI:
https://doi.org/10.3889/oamjms.2023.9154Keywords:
HL-1 cel, μ (MOR), δ (DOR), κ (KOR), Morphine, Fentanyl, D-penicillamine(2,5)Abstract
BACKGROUND: The opioid system was mainly involved three types of opioid receptors (ORs): μ (MOR), δ (DOR) and κ (KOR). These ORs are activated by its agonist, a family of endogenous peptides: Endorphins, enkephalins, and dynorphins, respectively.
AIM: This study determined the OR mRNA on effects of agonists exogenous morphine, fentanyl, D-penicillamine (2,5) enkephalin, and ketazocine in HL-1 mouse cardiac myocytes.
MATERIALS AND METHODS: HL-1 mouse cardiac myocytes were treated with 10 μM morphine sulfate, 1 μM fentanyl,1 μM D-penicillamine (2,5) enkephalin, and 1 μM ketazocine. Total mRNAs were extracted and cDNA was synthesized and quantitative real-time polymerase chain reaction was used to analyze gene expression.
RESULTS: The data analysis of MOR, DOR and KOR mRNA expression on effect of morphine was shown less level than control (0.61-fold, 0.67-fold, and 0.65-fold), respectively. The morphine-induced ORs down-regulation, whereas enkephalin treatment demonstrated highly significantly increased in mRNA of DOR (6.3-fold, p = 0.002). As well as, KOR mRNA expression was found highly significant increased under effect of Ketazocine (7.16-fold, p = 0.004).
CONCLUSION: This study found DOR and KOR, but not MOR expressed in HL-1 mouse cardiac myocytes under activation of exogenous opioid analogists. These findings suggested that exogenous analogist’s opioids mimeses the endogenous analogist’s opioids.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Jutkiewicz EM. Correction to: Delta opioid receptor pharmacology and therapeutic applications. Handb Exp Pharmacol. 2018;247:C1-2. https://doi.org/10.1007/978-3-319-95133-1_1001 PMid:31309359
Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 1994;341(1):33-8. https://doi.org/10.1016/0014-5793(94)80235-1 PMid:8137918
Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115(6):1363-81. https://doi.org/10.1097/ALN.0b013e318238bba6 PMid:22020140
Wei LN. Epigenetic control of the expression of opioid receptor genes. Epigenetics. 2008;3(3):119-21. https://doi.org/10.4161/ epi.3.3.6296 PMid:18497574
Koneru A, Satyanarayana S, Rizwan S. Endogenous opioids: Their physiological role and receptors. Glob J Pharmacol. 2009;3(3):149-53.
Przyklenk K. Reduction of myocardial infarct size with ischemic “conditioning”: Physiologic and technical considerations. Anesth Analg. 2013;117(4):891-01. https://doi.org/10.1213/ANE.0b013e318294fc63 PMid:23960036
Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R.
Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev. 2014;66(4):1142-74. https://doi.org/10.1124/pr.113.008300 PMid:25261534
Wong GT, Ling JL, Irwin MG. Activation of central opioid receptors induces cardioprotection against ischemia-reperfusion injury. Anesth Analg. 2010;111(1):24-8. https://doi.org/10.1213/ANE.0b013e3181b8b77e PMid:19861363
Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, et al. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol. 2008;294(3):H1444-51. https://doi.org/10.1152/ajpheart.01279.2006 PMid:18203844
Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: Evidence suggesting cross-species protection. Clin Sci (Lond).2009;117(5):191-200. https://doi.org/10.1042/CS20080523 PMid:19175358
Gwag HB, Kim EK, Park TK, Lee JM, Yang JH, Song YB, et al. Cardioprotective effects of intracoronary morphine in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A prospective, randomized trial. J Am Heart Assoc. 2017;6(4):e005426. https://doi.org/10.1161/JAHA.116.005426 PMid:28373244
Guo H, Pei J, Wang K, Liu Z, Zhang F, Wang K, et al. κ-Opioid receptor activation promotes mitochondrial fusion and enhances myocardial resistance to ischemia and reperfusion injury via STAT3-OPA1 pathway. Eur J Pharmacol. 2020;874:172987. https://doi.org/10.1016/j.ejphar.2020.172987 PMid:32032598
Wong GT, Li R, Jiang LL, Irwin MG. Remifentanil post- conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation. Acta Anaesthesiol Scand. 2010;54(4):510-8. https://doi.org/10.1111/j.1399-6576.2009.02145.x PMid:19878098
Salemi S, Aeschlimann A, Reisch N, Jungel A, Gay RE, Heppner FL, et al. Detection of kappa and delta opioid receptors in skin--outside the nervous system. Biochem Biophys Res Commun. 2005;338(2):1012-7. https://doi.org/10.1016/j.bbrc.2005.10.072 PMid:16263089
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402-8. https://doi.org/10.1006/meth.2001.1262 PMid:11846609
Feng Y, He X, Yang Y, Chao D, Lazarus LH, Xia Y. Current research on opioid receptor function. Curr DrugTargets. 2012;13(2):230-46. https://doi.org/10.2174/138945012799201612 PMid:22204322
Caputi FF, Acquas E, Kasture S, Ruiu S, Candeletti S, Romualdi P. The standardized Withania somnifera dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells. BMC Complement Altern Med. 2018;18(1):9. https://doi.org/10.1186/s12906-017-2065-9 PMid:29316911
Peng J, Sarkar S, Chang SL. Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. Drug Alcohol Depend. 2012;124(3):223-8. https://doi.org/10.1016/j.drugalcdep.2012.01.013 PMid:22356890
Lu Y, Hu J, Zhang Y, Dong C. Spinal neuronal NOS activation mediates intrathecal fentanyl preconditioning induced remote cardioprotection in rats. Int Immunopharmacol. 2014;19(1):127-31. https://doi.org/10.1016/j.intimp.2014.01.013 PMid:24462544
Peart JN, Patel HH, Gross GJ. Delta-opioid receptor activation mimics ischemic preconditioning in the canine heart. J Cardiovasc Pharmacol. 2003;42(1):78-1. https://doi.org/10.1097/00005344-200307000-00012 PMid:12827030
Tanaka K, Kersten JR, Riess ML. Opioid-induced cardioprotection. Curr Pharm Des. 2014;20(36):5696-705. https://doi.org/10.2174/1381612820666140204120311 PMid:24502571
Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res. 2004;94(7):960-6. https://doi.org/10.1161/01.RES.0000122392.33172.09 PMid:14976126
Karlsson LO, Bergh N, Li L, Bissessar E, Bobrova I, Gross GJ, et al. Dose-dependent cardioprotection of enkephalin analogue eribis peptide 94 and cardiac expression of opioid receptors in a porcine model of ischaemia and reperfusion. Eur J Pharmacol. 2012;674(2-3):378-83. https://doi.org/10.1016/j.ejphar.2011.11.012 PMid:22119384
Downloads
Published
How to Cite
License
Copyright (c) 2023 Waleed Al Abdulmonem (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
